IBI37G5
IBI37G5 is a human monoclonal antibody (mAb) targeting TNFRSF18/GITR/CD357. IBI37G5 has anti-tumor activity in MC38 and B16F10 mouse tumor models. IBI37G5 can be used in the study of cancer immunity[1].
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[IBI37G5]
References & Citations
[1]Liu H, et al. Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity. Cell Rep Med. 2022 Jun 21;3 (6) :100660.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
034841-HRP 200 µL
DTX3, NT (DTX3, RNF154, Probable E3 ubiquitin-protein ligase DTX3, Protein deltex-3, RING finger protein 154) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details